TU
TARO

TDAM USA’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

TDAM USA’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,634
Closed -$1.06M – 395
2016
Q3 		$1.06M Buy
9,634
+2,349
+32% +$311K 0.05% 218
2016
Q2 		$1.06M Sell
7,285
-570
-7% -$80.8K 0.05% 213
2016
Q1 		$1.13M Sell
7,855
-8,635
-52% -$1.23M 0.05% 209
2015
Q4 		$2.55M Buy
+16,490
New +$2.41M 0.12% 135

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TDAM USA's TARO Position: Q4 2016 in Review

TDAM USA sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 9,634 shares — an estimated $1.06M sold.

TDAM USA first reported a position in TARO in Q4 2015 and held it in 4 quarters. The position peaked at $2.55M in Q4 2015. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • TDAM USA reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • TDAM USA sold 9,634 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $1.06M.
  • TDAM USA first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 4 quarters.
  • TDAM USA's Taro Pharmaceutical Industries Ltd. position peaked at $2.55M in Q4 2015.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on TDAM USA's 13F filing for Q4 2016, filed 8 Feb 2017.